FindTrial
Sign In

remifentanil and neuroendocrin effect in stress by cesarean section

remifentanil and neuroendocrin effect in stress by cesarean section

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2005-003578-55-IT
Enrollment
Unknown
Registered
2007-04-04
Start date
2005-07-20
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

analgesia and anaesthesia for cesarean section MedDRA version: 6.1 Level: PT Classification code 10021723

Interventions

Trade Name: ULTIVA IV 5FL 1MG Pharmaceutical Form: Powder for infusion* INN or Proposed INN: Remifentanil CAS Number: 132539-07-2 Concentration unit: µg microgram(s) Concentration type: equal Concentr

Sponsors

POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026